Certified by Founder Lodge
Incyclix Bio
United States - Durham, North Carolina
START UP
1 Disclosed Funding Rounds $11,250,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Incyclix Bio, LLC is a next-generation cell cycle control company, advancing precision treatments that target the aberrant proliferation driving many cancers. The company’s lead compound is a
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 26 ,2025 | Series B | $11,250,000 |
Cape Fear BioCapital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Jupid | $840,000 | (May 1, 2026)
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
